These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 2238756)
1. Comparison of GLP-1 (7-36amide) and GIP on release of somatostatin-like immunoreactivity and insulin from the isolated rat pancreas. Schmid R; Schusdziarra V; Aulehner R; Weigert N; Classen M Z Gastroenterol; 1990 Jun; 28(6):280-4. PubMed ID: 2238756 [TBL] [Abstract][Full Text] [Related]
2. Glucagon-like peptide-1 secretion is influenced by perfusate glucose concentration and by a feedback mechanism involving somatostatin in isolated perfused porcine ileum. Hansen L; Hartmann B; Mineo H; Holst JJ Regul Pept; 2004 Apr; 118(1-2):11-8. PubMed ID: 14759551 [TBL] [Abstract][Full Text] [Related]
3. Effect of GIP, GLP-1, insulin and gastrin on ghrelin release in the isolated rat stomach. Lippl F; Kircher F; Erdmann J; Allescher HD; Schusdziarra V Regul Pept; 2004 Jun; 119(1-2):93-8. PubMed ID: 15093702 [TBL] [Abstract][Full Text] [Related]
4. Effects of glucagon-like peptide 1 (7-36) amide and glucagon on amylin release from perfused rat pancreas. Inoue K; Hisatomi A; Umeda F; Nawata H Horm Metab Res; 1991 Sep; 23(9):407-9. PubMed ID: 1743611 [TBL] [Abstract][Full Text] [Related]
5. Reduced insulinotropic effects of glucagonlike peptide I-(7-36)-amide and gastric inhibitory polypeptide in isolated perfused diabetic rat pancreas. Suzuki S; Kawai K; Ohashi S; Mukai H; Murayama Y; Yamashita K Diabetes; 1990 Nov; 39(11):1320-5. PubMed ID: 2146178 [TBL] [Abstract][Full Text] [Related]
6. Comparison of the effect of GIP and GLP-1 (7-36amide) on insulin release from rat pancreatic islets. Siegel EG; Schulze A; Schmidt WE; Creutzfeldt W Eur J Clin Invest; 1992 Mar; 22(3):154-7. PubMed ID: 1582439 [TBL] [Abstract][Full Text] [Related]
7. Carbachol priming increases glucose- and glucagon-like peptide-1 (7-36)amide-, but not arginine-induced insulin secretion from the isolated perfused rat pancreas. Fehmann HC; Göke R; Göke B; Arnold R Z Gastroenterol; 1990 Jul; 28(7):348-52. PubMed ID: 2238765 [TBL] [Abstract][Full Text] [Related]
8. The incretin hormones GIP and GLP-1 in diabetic rats: effects on insulin secretion and small bowel motility. Edholm T; Cejvan K; Abdel-Halim SM; Efendic S; Schmidt PT; Hellström PM Neurogastroenterol Motil; 2009 Mar; 21(3):313-21. PubMed ID: 19126188 [TBL] [Abstract][Full Text] [Related]
9. Prior in vitro exposure to GLP-1 with or without GIP can influence the subsequent beta cell responsiveness. Delmeire D; Flamez D; Moens K; Hinke SA; Van Schravendijk C; Pipeleers D; Schuit F Biochem Pharmacol; 2004 Jul; 68(1):33-9. PubMed ID: 15183115 [TBL] [Abstract][Full Text] [Related]
10. Interaction of glucagon-like peptide-1(7-36) amide and gastric inhibitory polypeptide or cholecystokinin on insulin and glucagon secretion from the isolated perfused rat pancreas. Suzuki S; Kawai K; Ohashi S; Watanabe Y; Yamashita K Metabolism; 1992 Apr; 41(4):359-63. PubMed ID: 1556941 [TBL] [Abstract][Full Text] [Related]
11. Secretion of incretin hormones (GIP and GLP-1) and incretin effect after oral glucose in first-degree relatives of patients with type 2 diabetes. Nauck MA; El-Ouaghlidi A; Gabrys B; Hücking K; Holst JJ; Deacon CF; Gallwitz B; Schmidt WE; Meier JJ Regul Pept; 2004 Nov; 122(3):209-17. PubMed ID: 15491793 [TBL] [Abstract][Full Text] [Related]
12. A comparison of the cellular and biological properties of DPP-IV-resistant N-glucitol analogues of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide. Green BD; Gault VA; O'Harte FP; Flatt PR Diabetes Obes Metab; 2005 Sep; 7(5):595-604. PubMed ID: 16050953 [TBL] [Abstract][Full Text] [Related]
13. Priming effect of glucagon-like peptide-1 (7-36) amide, glucose-dependent insulinotropic polypeptide and cholecystokinin-8 at the isolated perfused rat pancreas. Fehmann HC; Göke R; Göke B; Bächle R; Wagner B; Arnold R Biochim Biophys Acta; 1991 Feb; 1091(3):356-63. PubMed ID: 1705823 [TBL] [Abstract][Full Text] [Related]
14. Comparison of the effects of glucagon-like peptide-1-(1-37) and -(7-37) and glucagon on islet hormone release from isolated perfused canine and rat pancreases. Kawai K; Suzuki S; Ohashi S; Mukai H; Ohmori H; Murayama Y; Yamashita K Endocrinology; 1989 Apr; 124(4):1768-73. PubMed ID: 2564338 [TBL] [Abstract][Full Text] [Related]
15. Synergistic stimulatory effect of glucagon-like peptide-1 (7-36) amide and glucose-dependent insulin-releasing polypeptide on the endocrine rat pancreas. Fehmann HC; Göke B; Göke R; Trautmann ME; Arnold R FEBS Lett; 1989 Jul; 252(1-2):109-12. PubMed ID: 2668027 [TBL] [Abstract][Full Text] [Related]
16. Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients. Vilsbøll T; Krarup T; Madsbad S; Holst JJ Diabetologia; 2002 Aug; 45(8):1111-9. PubMed ID: 12189441 [TBL] [Abstract][Full Text] [Related]
17. Gastric inhibitory polypeptide and glucagon-like peptide-1(7-36) amide exert similar effects on somatostatin secretion but opposite effects on gastrin secretion from the rat stomach. Jia X; Brown JC; Kwok YN; Pederson RA; McIntosh CH Can J Physiol Pharmacol; 1994 Oct; 72(10):1215-9. PubMed ID: 7882187 [TBL] [Abstract][Full Text] [Related]